Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-obesity Prescription market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-obesity Prescriptionmarket, defines the market attractiveness level of Anti-obesity Prescription market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-obesity Prescription industry, describes the types of Anti-obesity Prescription market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-obesity Prescription market and the development prospects and opportunities of Anti-obesity Prescription industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-obesity Prescription market in Chapter 13.
By Player:
Zealand Pharma
Yungjin Pharm
Bridge BioResearch
Zydus Cadila
Arrowhead Research
Arena Pharmaceuticals
Compellis Pharmaceuticals
Akrimax Pharmaceuticals
Alpex Pharma
By Type:
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
By End-User:
Hospital Pharmacies
Retail Pharmacies
E-Commerce
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-obesity Prescription Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-obesity Prescription Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-obesity Prescription Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-obesity Prescription Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-obesity Prescription Market Analysis and Outlook to 2022
-
7.1 Global Anti-obesity Prescription Consumption (2017-2022)
-
7.2 United States Anti-obesity Prescription Consumption (2017-2022)
-
7.3 Europe Anti-obesity Prescription Consumption (2017-2022)
-
7.4 China Anti-obesity Prescription Consumption (2017-2022)
-
7.5 Japan Anti-obesity Prescription Consumption (2017-2022)
-
7.6 India Anti-obesity Prescription Consumption (2017-2022)
-
7.7 South Korea Anti-obesity Prescription Consumption (2017-2022)
8 Region and Country-wise Anti-obesity Prescription Market Analysis and Outlook to 2028
-
8.1 Global Anti-obesity Prescription Consumption Forecast (2022-2028)
-
8.2 United States Anti-obesity Prescription Consumption Forecast (2022-2028)
-
8.3 Europe Anti-obesity Prescription Consumption Forecast (2022-2028)
-
8.4 China Anti-obesity Prescription Consumption Forecast (2022-2028)
-
8.5 Japan Anti-obesity Prescription Consumption Forecast (2022-2028)
-
8.6 India Anti-obesity Prescription Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-obesity Prescription Consumption Forecast (2022-2028)
9 Global Anti-obesity Prescription Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-obesity Prescription Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bupropion and Naltrexone Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Orlistat Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lorcaserin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Phentermine and Topiramate Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Liraglutide Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-obesity Prescription Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global E-Commerce Consumption and Growth Rate (2017-2022)
10 Global Anti-obesity Prescription Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-obesity Prescription Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bupropion and Naltrexone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Orlistat Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Lorcaserin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Phentermine and Topiramate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Liraglutide Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-obesity Prescription Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-obesity Prescription Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-obesity Prescription Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-obesity Prescription Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-obesity Prescription Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-obesity Prescription Market Competitive Analysis
-
14.1 Zealand Pharma
-
14.1.1 Zealand Pharma Company Details
-
14.1.2 Zealand Pharma Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Zealand Pharma Anti-obesity Prescription Product and Service
-
14.2 Yungjin Pharm
-
14.2.1 Yungjin Pharm Company Details
-
14.2.2 Yungjin Pharm Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Yungjin Pharm Anti-obesity Prescription Product and Service
-
14.3 Bridge BioResearch
-
14.3.1 Bridge BioResearch Company Details
-
14.3.2 Bridge BioResearch Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bridge BioResearch Anti-obesity Prescription Product and Service
-
14.4 Zydus Cadila
-
14.4.1 Zydus Cadila Company Details
-
14.4.2 Zydus Cadila Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Zydus Cadila Anti-obesity Prescription Product and Service
-
14.5 Arrowhead Research
-
14.5.1 Arrowhead Research Company Details
-
14.5.2 Arrowhead Research Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Arrowhead Research Anti-obesity Prescription Product and Service
-
14.6 Arena Pharmaceuticals
-
14.6.1 Arena Pharmaceuticals Company Details
-
14.6.2 Arena Pharmaceuticals Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Arena Pharmaceuticals Anti-obesity Prescription Product and Service
-
14.7 Compellis Pharmaceuticals
-
14.7.1 Compellis Pharmaceuticals Company Details
-
14.7.2 Compellis Pharmaceuticals Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Compellis Pharmaceuticals Anti-obesity Prescription Product and Service
-
14.8 Akrimax Pharmaceuticals
-
14.8.1 Akrimax Pharmaceuticals Company Details
-
14.8.2 Akrimax Pharmaceuticals Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Akrimax Pharmaceuticals Anti-obesity Prescription Product and Service
-
14.9 Alpex Pharma
-
14.9.1 Alpex Pharma Company Details
-
14.9.2 Alpex Pharma Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Alpex Pharma Anti-obesity Prescription Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-obesity Prescription
-
Figure Anti-obesity Prescription Picture
-
Table Global Anti-obesity Prescription Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-obesity Prescription Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-obesity Prescription Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-obesity Prescription Consumption by Country (2017-2022)
-
Figure United States Anti-obesity Prescription Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-obesity Prescription Consumption and Growth Rate (2017-2022)
-
Figure China Anti-obesity Prescription Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-obesity Prescription Consumption and Growth Rate (2017-2022)
-
Figure India Anti-obesity Prescription Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-obesity Prescription Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-obesity Prescription Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-obesity Prescription Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-obesity Prescription Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-obesity Prescription Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-obesity Prescription Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-obesity Prescription Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-obesity Prescription Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bupropion and Naltrexone Consumption and Growth Rate (2017-2022)
-
Figure Global Orlistat Consumption and Growth Rate (2017-2022)
-
Figure Global Lorcaserin Consumption and Growth Rate (2017-2022)
-
Figure Global Phentermine and Topiramate Consumption and Growth Rate (2017-2022)
-
Figure Global Liraglutide Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global E-Commerce Consumption and Growth Rate (2017-2022)
-
Figure Global Bupropion and Naltrexone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Orlistat Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lorcaserin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phentermine and Topiramate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liraglutide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-obesity Prescription Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-obesity Prescription Export by Region (Top 5 Countries) (2017-2028)
-
Table Zealand Pharma (Foundation Year, Company Profile and etc.)
-
Table Zealand Pharma Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zealand Pharma Anti-obesity Prescription Product and Service
-
Table Yungjin Pharm (Foundation Year, Company Profile and etc.)
-
Table Yungjin Pharm Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yungjin Pharm Anti-obesity Prescription Product and Service
-
Table Bridge BioResearch (Foundation Year, Company Profile and etc.)
-
Table Bridge BioResearch Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bridge BioResearch Anti-obesity Prescription Product and Service
-
Table Zydus Cadila (Foundation Year, Company Profile and etc.)
-
Table Zydus Cadila Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Anti-obesity Prescription Product and Service
-
Table Arrowhead Research (Foundation Year, Company Profile and etc.)
-
Table Arrowhead Research Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Research Anti-obesity Prescription Product and Service
-
Table Arena Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arena Pharmaceuticals Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arena Pharmaceuticals Anti-obesity Prescription Product and Service
-
Table Compellis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Compellis Pharmaceuticals Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Compellis Pharmaceuticals Anti-obesity Prescription Product and Service
-
Table Akrimax Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Akrimax Pharmaceuticals Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akrimax Pharmaceuticals Anti-obesity Prescription Product and Service
-
Table Alpex Pharma (Foundation Year, Company Profile and etc.)
-
Table Alpex Pharma Anti-obesity Prescription Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alpex Pharma Anti-obesity Prescription Product and Service
-
